Company Filing History:
Years Active: 2025
Title: Alhaji Cherif: Innovator in Acid-Base Homeostasis
Introduction
Alhaji Cherif is a notable inventor based in Kew Gardens, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of acid-base homeostasis. His innovative work has the potential to enhance patient care and improve clinical outcomes.
Latest Patents
Cherif holds a patent for "Techniques for determining acid-base homeostasis." This technology encompasses processes designed to model acid-base homeostasis in both normal patients and those experiencing acid-base disorders. The method involves an acid-base homeostasis analysis, utilizing a physiological acid-base model configured to simulate a virtual patient's condition. This model determines various operating parameters for an HCO/CO buffering system, which includes renal and pulmonary regulatory mechanisms. Additionally, it calculates acid-base information such as bicarbonate concentration, carbon dioxide concentration, and free hydrogen ions concentration, ultimately predicting patient information based on these parameters. Cherif's patent represents a significant advancement in understanding and managing acid-base balance in patients.
Career Highlights
Alhaji Cherif is associated with Fresenius Medical Care Holdings, Inc., where he applies his expertise in medical technology. His work at this esteemed company allows him to collaborate with other professionals in the field, contributing to innovative solutions in healthcare.
Collaborations
Cherif has worked alongside notable colleagues such as Peter Kotanko and Doris Helen Fuertinger. These collaborations have fostered a productive environment for research and development, leading to advancements in medical technology.
Conclusion
Alhaji Cherif's contributions to the field of acid-base homeostasis through his patent and work at Fresenius Medical Care Holdings, Inc. highlight his role as an innovator in medical technology. His efforts are paving the way for improved patient care and understanding of acid-base disorders.